Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CMO | Ann: Notice of Change in Officer's Interests | 08/03/24 | 0 | 31 | |||
|
|||||||
CMO | Ann: Notice of Change in Officer's Interests | 08/03/24 | 0 | 37 | |||
|
|||||||
CMO | Ann: Notice of Change in Officer's Interests | 08/03/24 | 0 | 32 | |||
|
|||||||
CMO | Ann: Notice of Change in Director's Interests | 08/03/24 | 0 | 34 | |||
|
|||||||
CMO | Ann: Half Year Result to 31 December 2023 | 21/02/24 | 0 | 42 | |||
|
|||||||
CMO | Ann: Guidance Update | 18/01/24 | 0 | 66 | |||
|
|||||||
CMO | Ann: 2023 Annual Meeting results | 10/11/23 | 0 | 75 | |||
|
|||||||
CMO | Ann: Chair's Address and Presentations to 2023 Annual Meeting | 10/11/23 | 0 | 89 | |||
|
See All Discussions